Clinical outcomes and important prognostic biomarkers following dose-dense sequential adjuvant chemotherapy (dds-CT) in early breast cancer (eBC): Pooled-analysis of individual patient data

2025·

A. Goussia

,

F.I.D. Dimitrakopoulos

Nikolaos Korfiatis

,

T. Koletsa

,

A. Batistatou

,

H.P. Kourea

,

M. Bobos

,

K. Papadopoulou

,

A.V. Charchanti

,

M. Bai

,

O. Tzaida

,

K. Petraki

,

P. Arapantoni-Dadioti

,

A. Psyrri

,

H. Gogas

,

F. Zagouri

,

G. Fountzilas

NCT04829890 Cite DOI

Journal Article Clinical Trial

Authors

Nikolaos Korfiatis

Professor of Data Management and Analytics

Professor of Data Management and Analytics at the Department of Informatics, Ionian University, Corfu. Senior Statistician of the Hellenic Cooperative Oncology Group (HeCOG).

---

← Bitcoin's Edge: Embedded Sentiment in Blockchain Transactional Data 2025

Clinico-pathological and genomic features of HER2-low early Breast Cancer (eBC). Results of retrospective analysis of seven adjuvant trials by the Hellenic Cooperative Oncology Group (HeCOG) 2025 →